CannabIP: U.S. Patent No. 9,901,607 B2

U.S. Patent No. 9,901,607 B2 issued on February 27, 2018, to Mark J. Silen, directed to compositions and method of manufacture of preparing and manufacturing smokeless controlled release of cannabinoids. The specification describes an oral composition including from the cannabis plant material and an additive solution. The cannabis plant material can include any strain from the cannabis genus, including C. sativa, C. indica, or C. ruderalis. The specific embodiments could include material from the cola or the leaves. The additive solution can compose a variety of ingredients, including distilled grain alcohol or extract oil. Independent claim 1 recites an oral composition including cannabis material and an additive comprising honey and an extract of THC oil. Independent claim 12 is a method claim for manufacturing the cannabis composition, and includes steps for adding the additive, fermentation, and heating of the composition. Independent claim 23 recites a further oral composition including cannabis material and an additive comprising honey, the yeast Saccharomyces cerevisiae, and an extract. The searched Cooperative Patent Classification is A61K (preparations for medical, dental or toilet purposes).

The following is Figure 1 of the claimed invention:

Source: U.S. Patent No. 9,901,607, Feb. 27, 2018, to Mark J. Silen

This is another example of a patent issued to a sole inventor/applicant. More cannabis technology is expected to begin the patenting process as more states become friendlier to adult-use cannabis, both in research and recreational use. Please contact Yonaxis for more information on patent processes if you have any questions.